University of South Carolina Libraries
Main Street CONTINUED FROM PAGE 1 North Main Street is a primary commuter route from Columbia’s northeast suburbs and downtown, as well as a connection to Interstate 20. Piper’s criteria for improving the corridor include four aspects: safety, security, access and aes thetics. Focusing on the road and the area near the road, the streetscaping will involve four ma jor changes to the area. First on the list of modifications I are those for pedestrians. The city will replace the sidewalks, add brick-layer crosswalks and install Intelligent Transportation Systems crosswalk packages. Those packages comprise cross walk signs that include count downs; microwave detectors, which detect the presence of pedestrians; and improved light ing. The city will also realign sev eral intersections to make them easier to cross. ' ' Other improvements will be geared toward bikers. Some of the funding will be used for a need based helmet giveaway for area res idents. Stripes will be added to trav el lanes so that bike riders know where to ride. Bus riders will see new and more numerous bus shelters, benches and turnouts. Routes will be clearly marked on signs to help riders find their way. The street itself will be ex panded to add turnoff lanes. North - Main Street has only periodic left and right-tum-only lanes at inter sections. The programming of the traffic lights will also be modified so that their timing is more ap propriate,for the traffic. Planners for the North Main Street Improvement Project hope -1 the street changes will improve the Level of Service rating of North Main intersections. The LOS grade ranks intersection performance it records the average time that mo torists are stopped at traffic lights. Several North Main intersec tions, which commonly have wait times of 40 or more seconds, have received failing grades by LOS standards. If all goes according to plan, after the project’s comple tion in 2006, seven street intersec tions will be out of the red, four with a grade of A. The city even plans to rezone some of the street. “We’re floating an idea about an overlay district to address signage, to complement what’s being done,” said Chip Land, the city’s deputy director of zoning. An overlay zone would reduce highway-style commercial devel opment by outlawing large-sign advertising, he said. Businesses would be encouraged to use back lot parking and build their offices closer to the street. Not all the residents of Eau Claire, the suburb near North Main, support the change. Several residents expressed then dissension at a public meeting Monday. Some complained that the beau tification would increase traffic along the intersection of Main Street and Sunset Drive. One said he saw backups from the area go ing back to Elmwood Avenue from 3 to 6 p.m. daily. Another said the technological improvements will take place only along the corridor of Main Street and would not extend past the street; he wanted the changes to also benefit nearby neighborhoods. Others said the meetings would never bring the project to fruition. The counsel has been discussing the changes since 1999. “The reason we have so many meetings is to get their input,” Piper said. “This counsel could, if you wanted, plan it all without input and be done in three months.” “People are always against change,” he said, “and they al ways want their specific problem fixed.” Barring major problems, the project will begin in 2004 and fin Comments on this story?E-mail gamecockudesk@hotmail.com As part of a project to Td beautify North Main Street, the city will replace sidewalks and add brick-layer crosswalks and bike lanes. PHOTO BY PETER GIOELLO/THE GAMECOCK What is little Johnny - and Deborah, Ali, Sarala - learning about religions in school? Religious Intolerance in Our Multi-Faith Society [ a free public event ] * October 26 7:00 - 9:15pm. Gambrell Hall Auditorium, USC October 27 2:00-9:15pm. Law School Auditorium, USC For more information call, 803.777.4522 or visit, www.cla.sc.edu/RELG/partners/pind/pindspec.html This event is offered by the U.S. Conference of Religions for Peace as part of a national series of 12 symposia on diversity issues funded by the Rockefeller Foundation. Event collaborators include Partners in Dialogue, the Department of Religious Studies at the University of South Carolina, and the South Carolina Humanities Council. BRIEFLY Film to hold casting call in Walterboro The feature film “Radio,” star ring Cuba Gooding Jr. and Ed Harris, is holding an open cast ing call Oct. 24 and 25 between 2 p.m. and 8 p.m. at the Quality Inn in Walterboro for male football and basketball players. All applicants must be male and between the ages of 18 and 25, must have at least high school experience in their sport, and must not be NCAA colle giate athletes. Interested play ers are advised not to cut their hair because of the 1970s time period the film tries to capture. Players chosen for significant positions will be paid. “Radio” will be filming in Walterboro, S.C., through December. The movie is based on the true story of a T. L. Hanna High School coach, played by Ed Harris, and a mentally handi capped man, played by Cuba Gooding Jr. Their relationship causes their small community in Anderson, S. C., to divide, then alter their preconceptions and fi- l nally unite once again. The creators of “Radio” are also involved in such other fea ture films as “Finding Forester,” “The Rookie,” “Varsity Blues,” “Summer Catch” and “Hard BaU.” The Quality Inn at 1286 Sniders Highway (Highway 63), is located off Interstate 95 at exit 53. Interested players may call the Player Hotline at (843) 538-6335 or log onto www.reelsportssolu tions.com. Moving from anger to action BY ALLYSON BIRD TIIK GAMECOCK Yossi Klein Halevi was the first member of his family in New York City to be born after the Holocaust, and his father was a survivor who hid in a forest hole. “My father was an angry sur vivor. The anger included most of the non-Jewish population," Halevi said. “I saw the world through the constricted lens of my father’s hole in the forest.” Halevi is an Israeli journalist and citizen of Jerusalem who writes regularly for the Los Angeles Times. He joined Rhett Jackson, a local United Methodist church member, and Imam Omar Shaheed of Masjid As-Salaam to lead a panel discussion at the College of Nursing. The three ex plained their personal escapes from religious prejudice. The pan el was part of the Solomon Tenenbaum Lectureship titled “From Exclusion to Embrace: A Jew, A Christian and A Muslim Tell Their Stories.” Halevi began the discussion de scribing his childhood. His entire neighborhood had been composed of “similarly trau matized people” such as his father. Halevi would even cross the street before passing the nearby church as a child. To him, it represented hatred toward his faith. many c,nrisuans aon t realize how Jews fear Christianity and especially the cross,” he said. As a teenager, Halevi joined the Jewish Defense League, which he candidly names a radi cal group of the ’60s and ’70s. Although Halevi accused the league’s leaders of racism, he stayed involved because his peo ple were being represented. “We felt a deep sense of betray al against the American Jewish population,... which had not done enough to save the Jews” during i the Holocaust, he said. Halevi learned in college that his mentality was skewed, he said, and he eventually fell in love with and married a Christian woman who later converted to Judaism. He moved to Israel in 1982. “It was the great Jewish ad venture of our lifetime, and I didn’t want to be a spectator,” he said. It was in Israel that he dis covered that “rage was no longer ♦ JOURNALIST, SEE PAGE 7 IContraceptive InjectionI eor\trol you*kinka&ou-t jus-t +*a*sar medroxyprogesterone acetate injectable suspension , ___~_ DEPO-PROVERA Contraceptive Injection (medroxyprogesterone acetate injectable suspension, USP) This product is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually transmitted diseases. What is DEPO-PROVERA Contraceptive Injection? DEPO-PROVERA Contraceptive Injection is a form of brth control that ^gven .at an ■ntramuscUar injection {a shot) m the buttock or upper ami once every 3 months (13 weeksf continue your contraceptive protection, you must return for your next injection promptly at the end of 3 months (13 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a chemical similar to (but not the same as) the natural hormone progesterone, which is produced by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by preventing your egg ce*s from ripening. If an egg is not released from the ovaries during your menstrual cycle, it cannot become ferfctoed by sperm and result in pregnancy DEPO-PROVERA also causes changes m the lining ofyour uterus that make ft less likely for pregnancy to occur How effective is DEPO-PROVERA Contraceptive Injection? The efficacy of DEPO-PROVERA Contraceptive injection depends on following tlie recommended dosage schedule exactly (see 'How often do I get my shot of DEPO-PROVERA Contraceptive infection?"). To make sure you are not pregnant when you first get DEPO-PROVERA Contraceptive Injection, your first injection must- be given ONLY dunng the first 5 days of a normal menstrual period; ONLY within the first 5 days after chWbnth if not breast-feeding; and. if exclusively bieast-feeduig. ONLY at the sixth week after childbirth. It is a long-term injectabie contraceptive when administered at 3-month (13-week) intervals. DEPO-PRO/bRA Contraceptive Injection is over 99% effective, making it one of the most reliable methods of birth control available. Thu means tint the average annua pregnancy rate is less ttian one for every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptive methods depends in part on how reliably each woman uses tt*e method The effectiveness of DEPO-PROVERA depends only on the patient returning every 3 months (13 weeks) for her next injection Your heath-care provider wil help you compare DEPO-PROVERA with other contraceptive methods and give you the information you need in order to decide which contraceptive method is tlie right choice for you The following table stows the percent of'women who got pregnant while using different kinds of contraceptive methods. It gives both the lowest expected rate of pregnancy (the rate expected in women vyho use each method exactly as it should be used) and the typical rate of pregnancy (which mdudes women who became pregnant because they forgot to use their birth control or because they did not fatow the directions exactly). Percent of Women Experiencing an Accidental Pregnancy in the First Year of Continuous Use Lowest Method_ Expect_Typical OfPO-PRCMPA03Q3 knptmii (Nwpl**)0 2* QT* ferrule sttmteaucr,_ 02 0* M*e stertuaton ’Qi0|* Oal contraceptive (p*l) Comtwied Oil Progestogen only 0-5 ; ---3 - 3 Pmgestasert 2b Cooper T 380A_08_ :__ Condom (without spermicide) __ 2_ J2___ OdpK-iigm (with «p*rrncido)__6___18 Cervical cap6_ __*! _Withdrawal_______d__ 18_ flenodx abstinenceM__20_ Spemxdte atone ....32 j Vaginal Sponge used before <h*Jtxrth 6 _ used after childbirth__2__;_ 28 _ Nfcmyfyj , , Si.. ft — Source truss** et altDMtt-t Gynecol. 1990;76558-S6?. •from Norplant* package Insert Who should not use DEPO-PROVERA Contraceptive Injection? Not ail women should use DEPO-PROVERA. You shouM not use DEPO-PRO/ERA if you have any of the following conditions; ♦ if you think you might be pregiant * if you have any vaginal bleed mg without a known reason • if you have had cancer of the breast • if you have ted a stroke • if you haive or have had blood clots (phlebitis) in your legs • tf you have problems with your fiver or liver disease • if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other ingredients). What other things should f consider before using DEPO-PROVERA Contraceptive Injection? You wdl have a physical, examination before your doctor prescribes DEPO-PROVERA. tf s important to tell your health-care provider if you have any of the fofiowing. • a family history of breast cancer • an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or bleeding from your nipples • kidney disease • irregular or scanty menstrual penods • high blood pressure • migraine headaches • asthma • epilepsy (convulsions or seizures) • diabetes or a family history of diabetes • a history of depression • if you are taking any prescription or over-the-counter medications This product is intended to prevent pregnancy. It does not protect against transmission of HIV (AIDS) and other sexually transmitted diseases such as chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis. What if I want to become pregnant after using DEPO-PROVERA Contraceptive Injection? Because DEPO-PROVERA is a long-acting birth control method, it takes some time after your last injection for its effect to wear off Based on the results from a large study done in the United States, for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that about half of those who become pregnant wHI do so in about 10 months after their- last injection, about two thirds of those who become pregnant will do so m about 12 months: about 83% of those who become pregnant wifi do so in about 15 months, and about 93% of those who become piegpant wilt do so in about 18 months after their last injection. The length of time you use DEPO-PROv'ERA has no effect on how long it takes/ou to become pregnant after you stop using it What are the risks of using DEPO-PROVERA Contraceptive Injection? I SnegukK Meminiai Bleeding The side effect reported most frequently by women who use DEPO-PROVERA for contraception is a change in their normal menstrual cycle Dunng the first year of using DEPO-PROVERA. you might have one or more of the toflowing changes: irregular or unpredictable Weeding or spotting, an increase or decrease m menstrual Weeding, or no Weeding at all. Unusually heavy or continuous Weeding, however, is not a usual effect of DtPO-PROVERA. and if this happens, you should see your health-care provider right away. With continued use of DEPO-PROVERA, Weeding usually decreases, and many women stop having penods completely. In clinical studies of DEPO-PROVERA. 55% of the women studied reported no menstrual Weeding (amenorrhea) after l year of use, and 68% of the women studied reported no menstrual bleeding after 2 years of use The reason that your penods stop is because DEPO-PROVERA causes a resting state in your ovanes. When your ovaries do not release an egg monthly, the regular monthly growth of the lining of your uterus does not occur and, therefore, the Weeding that comes with your normal menstruation does not take place. When you stop using DEPO-PROVERA your menstrual period will usually, in time, return to its no»mal cycle. 2.Bone Mineral Changes . . , , Use of DEPO-PROVERA may be associated with a decrease m the amount of mineral stored in your bones. This could increase your nsk of developing bone fractures. The rate of bone mineral loss is greatest in the early years of DEPO- PROVE RA use, but after that, it begins to resemble the normal rate of age-related bone mineral loss. SCancer Studies of women wfio have used different forms of contraception found that women who used DEPO-PROVERA for contraception had no increased overall nsk of developing cancer of the breast ovary, uterus, cervix, or liver. However women under 35 yea s of age whose first exposure to DEPO-PROVERA was within the previous 4 to 5 years may have a slightly increased nsk of developing breast oncer similar to that seen with oral contraceptives. You should discuss this with your health-care provider 4.Unexpected Pregnancy Because DEPO-PROVERA is such an effective contraceptive method, the risk of accidental pregnancy for women who get their shots regiiarfy (every 3 months [13 weeks]) is very low. White there have been reports of an increased risk of low birth weight and neonatal infant death or otlter health problems m infants conceived close to the time of Section, such pregnancies are uncommon. If you think you may have become pregnant white using DEPO-PROVERA for contraception, see your health-care provider as soon as possible. SAtiergc Reactions Some women using DEPO-PROVERA Contraceptive flection have reported severe and potentially life-threatenmg allergic reactions known as anaphylaxis and anaphylactoid reactions. Symptoms include the sudden onset of hives or swelling and itching of the skin. Wreathing difficulties, and a cteop in Wood pressure. d.Ofher Risks , .. ... . . . Women who use hormone based contraceptives may hare an increased nsk of Wood clots or stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should tell your health-care provider if you hare any of the problems listed in the wgsectioa What symptoms mav signal problems while using DEPO-PROVERA Contraceptive Injection? ., Call your lieafth-care provider immediately if any of these problems occur following an injection of DEPO-PROVERA: , _ ,, r . • shaip chest pain, coughing up of Wood, or sudden shortness of breath (indicating a possible dot in the lung) ,. . .. .. • sudden severe headache or vomiting, dizziness or fainting, problems with your eyesight or speech, weakness, or numbness m an arm or teg (***kahng a possible stroke) • severe pain or swelling m the calf (indicating a possible clot m the leg) • unusually heavy vagina Weeding • severe parn or tenderness n the tower abdominal area • persistent (jam, pus,or bleedng at the ______ What are the possible side effects of DEPO-PROVERA Contraceptive injection? You may experience a weight gam while you are using DEPO-PROVERA. About two thirds of the women who used DEPO-PROVERA m chmca! trials reported a wight gam of about 5 pounds diring the test year of use. You may continue to gam weight after the first year Women m one large study who used DEPO-PROVERA for 2 years gamed an average total of 8.1 pounds over those 2 years, or approximately 4 pounds per year Women who continued for 4 years gained an average total of 13.8 pounds over those 4 years, or approximately 35 pounds per year. Women who continued for 6 year's gamed an average total of 165 pounds over those 6 years, or approximately 2-75 pounds per year. In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some women reported the foflowmg effects that may or may not have been retted to their use of DEPO-PROVERA: irregular menstrual bleeding, amenorrhea, headache, nervousness, abdominal cramps, doziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea, vagmal discharge or irritation, breast swelling and tenderness, bloating, swelling of the hands or feet, backache, depression, insomnia, acne, pelvic pain, no hair g-owth or excessive ham loss. rash, hot flashes, and joint pain. Other problems were reported by very few of the women in the clinical trials, but some of these could be senous These include convulsions, jaundice, urinary tract infections- allergic reactions, fainting, paralysis, osteoporosis, iack of return to fertility, deep van thrombosis, pulmonary embolus, breast cancer or cervical cancer, if these or any other problems occur during your use of DEPO-PROVERA, discuss them with your heafth-careprovider: Should any precautions be followed during use of DEPO-PROVERA Contraceptive Injection? I Missed Periods During the time you are using DEPO-PROVERA for contraception, you may skip a period, or your periods may stop completely. If you have been receiving your DEPO-PROVERA injections regularly every 3 months (13 weeks), then you are probably not pregnant However, if you think that you may be pregnant, see your health-care provider 2laboratory Test frifieractiora If you are scheduled for any laboratory tests, tell your health care provider that you are using DtPO-PROVERA for contraception. Certain blood tests are affected by hormones such as DEPO-PROVERA. 3Dreg Interrxoons Cytadren (aminoglutethimide) is an anticancer drug that may Significantly decrease the effectiveness of DtPO-PROVERA if the two drugs are given during the same time. 4,/siursifw .Mothers Although DEPO-PROVERA can be passed to the nursing infant in the breast milk, no fwrmful effects have been found in these children. DEPO-PROVERA does not prevent the breasts from prodxing ntik. so it can be used by nursing mothers. However, to minimize the amount of DEPO-PROVERA that is passed to the infant in the first weeks after birth, you should wart until 6 weeks after childbirth before you start using DEPO-PROVERA for contraception How often do I get my shot of DEPO-PROVERA Contraceptive Injection? The recommended dose of DEPO-PRCJVERA is 150 mg every 3 months (13 weeks) given in a single intramuscular injection in the buttock or upper arm. To make sure that you are not pregnant at the time of the first Section, it is essential that the injection be given ONLY during the first 5 days of a norm* menstrual period. If used following the delivery of a child, the first injection of DEPO- PROVERA MUST be given within 5 days after childbirth if you are not breast- feeding or 6 weeks after childbirth if you are exclusively breast-feeding. If you wart longer than 3 months (13 weeks) between injections, or longer than 6 weeks after delivery, your health-care provider should determine that you are not piegnant before giving you your injection of' DEPO-PROVERA. Rx only CB-7-S • Pharmacia & Upjohn